Lantern Pharma Inc. Contracts & Agreements
35 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (3)
- Human Resources (14)
- Intellectual Property (6)
- Uncategorized (2)
- Amendment to Employment Agreement with David Margrave dated December 28, 2023 (Filed With SEC on March 18, 2024)
- Amendment to Employment Agreement with Kishor Bhatia dated December 28, 2023 (Filed With SEC on March 18, 2024)
- Fourth Amendment, dated January 1, 2023, to Employment Agreement with Kishor Bhatia dated May 18, 2020 (Filed With SEC on May 9, 2023)
- Second Amended and Restated 2018 Equity Incentive Plan dated October 20, 2022 (Filed With SEC on March 20, 2023)
- Third Amendment, dated August 1, 2022, to Employment Agreement with Panna Sharma dated July 23, 2018 (Filed With SEC on November 7, 2022)
- Third Amendment, dated May 1, 2022, to Employment Agreement with Kishor Bhatia dated May 18, 2020 (Filed With SEC on August 8, 2022)
- Second Amendment, dated May 1, 2022, to Employment Agreement with David Margrave dated May 18, 2020 (Filed With SEC on August 8, 2022)
- Description of Capital Stock (Filed With SEC on March 10, 2021)
- Amendment to Employment Agreement dated February 18, 2021 with Kishor G. Bhatia (Filed With SEC on March 10, 2021)
- Second Addendum to Technology License Agreement dated December 30, 2020 with AF Chemicals, LLC (Filed With SEC on January 8, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 8, 2021)
- API Services Project Agreement, dated July 10, 2020, between Patheon API Services, Inc. and Lantern Pharma Inc (Filed With SEC on October 29, 2020)
- Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma (Filed With SEC on June 8, 2020)
- Form of Amendment to Series A Preferred Stock Warrant (Filed With SEC on May 19, 2020)
- Employment Agreement dated May 18, 2020 with Kishor G Bhatia (Filed With SEC on May 19, 2020)
- Form of Lock-Up Agreement (Filed With SEC on May 19, 2020)
- Employment Agreement dated May 18, 2020 with David Margrave (Filed With SEC on May 19, 2020)
- Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma (Filed With SEC on May 19, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
- Specimen Stock Certificate evidencing shares of common stock (Filed With SEC on May 12, 2020)
- Form of Warrant (2017) (Filed With SEC on April 16, 2020)
- Form of Warrant (2014) (Filed With SEC on April 16, 2020)
- Form of Warrant (2019) (Filed With SEC on April 16, 2020)
- Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on April 16, 2020)
- Employment Agreement dated July 23, 2018 with Panna Sharma (Filed With SEC on April 16, 2020)
- Form of Indemnification Agreement (Filed With SEC on April 16, 2020)
- Amended and Restated Investors Rights Agreement (Filed With SEC on April 16, 2020)
- Amended and Restated Right of First Refusal and Co-Sale Agreement (Filed With SEC on April 16, 2020)
- Amended and Restated Voting Agreement (Filed With SEC on April 16, 2020)
- Technology License Agreement dated January 15, 2015, with AF Chemicals, LLC (Filed With SEC on April 16, 2020)
- Drug License and Development Agreement dated as of May 23, 2015 with Oncology Venture A/S (Filed With SEC on April 16, 2020)
- Addendum to Drug License and Development Agreement with Oncology Venture A/S dated February 8, 2016 (Filed With SEC on April 16, 2020)
- Amendment No. 2 to Drug License and Development Agreement with Oncology Venture A/S dated February 11, 2016 (Filed With SEC on April 16, 2020)
- Assignment Agreement dated as of January 5, 2018 with BioNumerik Pharmaceuticals, Inc (Filed With SEC on April 16, 2020)
- Addendum to Technology License Agreement dated February 8, 2016, with AF Chemicals, LLC (Filed With SEC on April 16, 2020)